株式会社ティムスのホームをご覧いただけます。
Location: Japan
Employees: 11-50
Investors 4
| Date | Name | Website |
| - | Okasan Cap... | okasancp.c... |
| - | Oita Ventu... | oita-vc.co... |
| - | MSIVC | msivc.co.j... |
| 03.06.2022 | Seiho Inve... | siwi.info |
Mentions in press and media 1
| Date | Title | Description |
| 12.05.2021 | BIOGEN INC. Biogen Announces Exercise of Option to Acquire the Investigational Drug TMS-007 for Acute Ischemic Stroke Based on Positive Phase 2a Data | TMS-007 has the potential to be a next generation thrombolytic with an improved benefit-risk profile Acute ischemic stroke is caused by a blockage of blood supply to the brain, and current thrombolytics are limited in use due in part to inc... |